Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: The screening study for undiagnosed atrial fibrillation (STUDY-AF)

Clinical Cardiology

Volumn 38, Issue 5, 2015, Pages 285-292

  Turakhia, Mintu P ^a,b   Ullal, Aditya J ^a   Hoang, Donald D ^a   Than, Claire T ^a   Miller, Jared D ^c   Friday, Karen J ^a,b   Perez, Marco V ^b   Freeman, James V ^d   Wang, Paul J ^b   Heidenreich, Paul A ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC VALUE; ELECTROCARDIOGRAPHY MONITORING; FAINTNESS; FEASIBILITY STUDY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; IMPLANTED HEART PACEMAKER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD; OUTCOME ASSESSMENT; OUTPATIENT; PREVALENCE; SILENT ATRIAL FIBRILLATION; SLEEP DISORDERED BREATHING; SUPRAVENTRICULAR TACHYCARDIA; TRANSIENT ISCHEMIC ATTACK; AMBULATORY ELECTROCARDIOGRAPHY; ASYMPTOMATIC DISEASE; MASS SCREENING; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; STROKE;

AGED; ASYMPTOMATIC DISEASES; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY, AMBULATORY; FEASIBILITY STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OUTPATIENTS; PROSPECTIVE STUDIES; STROKE;

EID: 84929702914     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22387     Document Type: Article

References (34)

1. Wolf PA, Abbott RD, Kannel WB,. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med. 1987; 147: 1561-1564.
2. Lin HJ, Wolf PA, Benjamin EJ, et al., Newly diagnosed atrial fibrillation and acute stroke. The Framingham Study. Stroke. 1995; 26: 1527-1530.
3. Flaker GC, Belew K, Beckman K, et al., Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005; 149: 657-663.
4. Cullinane M, Wainwright R, Brown A, et al., Asymptomatic embolization in subjects with atrial fibrillation not taking anticoagulants: a prospective study. Stroke. 1998; 29: 1810-1815.
5. Marfella R, Sasso FC, Siniscalchi M, et al., Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients. J Am Coll Cardiol. 2013; 62: 525-530.
6. Camm AJ, Lip GY, De Caterina R, et al., 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association [published corrections appear in Eur Heart J. 2013;34:790 and Eur Heart J. 2013;34:2850-2851]. Eur Heart J. 2012; 33: 2719-2747.
7. Goldstein LB, Bushnell CD, Adams RJ, et al., Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association [published correction appears in Stroke. 2011;42:e26]. Stroke. 2011; 42: 517-584.
8. 2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study. Am Heart J. 2011; 162: 555-561.
9. Benjamin EJ, Levy D, Vaziri SM, et al., Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994; 271: 840-844.
10. Turakhia MP, Hoang DD, Zimetbaum P, et al., Diagnostic utility of a novel leadless arrhythmia monitoring device. Am J Cardiol. 2013; 112: 520-524.
11. Rosenberg MA, Samuel M, Thosani A, et al., Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol. 2013; 36: 328-333.
12. Binici Z, Intzilakis T, Nielsen OW, et al., Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation. 2010; 121: 1904-1911.
13. Dewland TA, Vittinghoff E, Mandyam MC, et al., Atrial ectopy as a predictor of incident atrial fibrillation: a cohort study. Ann Intern Med. 2013; 159: 721-728.
14. Guyatt GH, Akl EA, Crowther M, et al,; American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [published corrections appear in Chest. 2012;141:1129 and Chest. 2012;142:1698]. Chest. 2012; 141 (2 suppl): 7S-47S.
15. January CT, Wann LS, Alpert JS, et al., 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2014; 130: 2071-2104.
16. Doliwa PS, Frykman V, Rosenqvist M,. Short-term ECG for out of hospital detection of silent atrial fibrillation episodes. Scand Cardiovasc J. 2009; 43: 163-168.
17. Engdahl J, Andersson L, Mirskaya M, et al., Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention. Circulation. 2013; 127: 930-937.
18. Gaillard N, Deltour S, Vilotijevic B, et al., Detection of paroxysmal atrial fibrillation with transtelephonic EKG in TIA or stroke patients. Neurology. 2010; 74: 1666-1670.
19. Jabaudon D, Sztajzel J, Sievert K, et al., Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke. 2004; 35: 1647-1651.
20. Sanmartín M, Fraguela Fraga F, Martín-Santos A, et al., A campaign for information and diagnosis of atrial fibrillation: "Pulse Week" [article in English, Spanish]. Rev Esp Cardiol (Engl Ed). 2013; 66: 34-38.
21. Tayal AH, Tian M, Kelly KM, et al., Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology. 2008; 71: 1696-1701.
22. Wheeldon NM, Tayler DI, Anagnostou E, et al., Screening for atrial fibrillation in primary care. Heart. 1998; 79: 50-55.
23. Seet RC, Friedman PA, Rabinstein AA,. Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause. Circulation. 2011; 124: 477-486.
24. Lowres N, Neubeck L, Redfern J, et al., Screening to identify unknown atrial fibrillation: a systematic review. Thromb Haemost. 2013; 110: 213-222.
25. Hart RG, Pearce LA, Aguilar MI,. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007; 146: 857-867.
26. Shah SV, Gage BF,. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation. Circulation. 2011; 123: 2562-2570.
27. Canestaro WJ, Patrick AR, Avorn J, et al., Cost-effectiveness of oral anticoagulants for treatment of atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2013; 6: 724-731.
28. Savelieva I, Camm AJ,. Practical considerations for using novel oral anticoagulants in patients with atrial fibrillation. Clin Cardiol. 2014; 37: 32-47.
29. Friberg L, Engdahl J, Frykman V, et al., Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP). Europace. 2013; 15: 135-140.
30. Reiffel J, Verma A, Halperin JL, et al., Rationale and design of REVEAL AF: a prospective study of previously undiagnosed atrial fibrillation as documented by an insertable cardiac monitor in high-risk patients. Am Heart J. 2014; 167: 22-27.
31. Healey JS, Connolly SJ, Gold MR, et al,; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012; 366: 120-129.
32. Glotzer TV, Daoud EG, Wyse DG, et al., The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol. 2009; 2: 474-480.
33. Ziegler PD, Glotzer TV, Daoud EG, et al., Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events. Stroke. 2010; 41: 256-260.
34. Ip J, Waldo AL, Lip GY, et al,; IMPACT Investigators. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study. Am Heart J. 2009; 158: 364.e1-370.e1.